Advertisement

Topics

Breakthrough status given to blood cancer drug

05:37 EDT 2 Aug 2017 | SmartBrief

The FDA awarded breakthrough status to AstraZeneca's blood cancer drug acalabrutinib to treat mantle cell lymphoma.  -More

Original Article: Breakthrough status given to blood cancer drug

NEXT ARTICLE

More From BioPortfolio on "Breakthrough status given to blood cancer drug"

Quick Search
Advertisement
 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...